
Alana Harris Dent
Examiner (ID: 7014)
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 1512 |
| Issued Applications | 526 |
| Pending Applications | 351 |
| Abandoned Applications | 660 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6195428
[patent_doc_number] => 20110027182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'SUBSTANCE FOR OBTAINING HIGHLY EFFECTIVE TUMOR MEDICATIONS AS WELL AS A PROCESS'
[patent_app_type] => utility
[patent_app_number] => 12/828579
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8309
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027182.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828579 | SUBSTANCE FOR OBTAINING HIGHLY EFFECTIVE TUMOR MEDICATIONS AS WELL AS A PROCESS | Jun 30, 2010 | Abandoned |
Array
(
[id] => 5958492
[patent_doc_number] => 20110182879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'NOVEL HUMAN TRANSFERASE FAMILY MEMBERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/828319
[patent_app_country] => US
[patent_app_date] => 2010-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 83
[patent_no_of_words] => 281551
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182879.pdf
[firstpage_image] =>[orig_patent_app_number] => 12828319
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/828319 | Human transferase family members and uses thereof | Jun 30, 2010 | Issued |
Array
(
[id] => 6538543
[patent_doc_number] => 20100221753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Macroarray Proteomics Platforms'
[patent_app_type] => utility
[patent_app_number] => 12/782599
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 50041
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221753.pdf
[firstpage_image] =>[orig_patent_app_number] => 12782599
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782599 | Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms | May 17, 2010 | Issued |
Array
(
[id] => 8312601
[patent_doc_number] => 20120189625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'Compositions and Methods for Treating Hematological Cancers Targeting the SIRPA CD47 Interaction'
[patent_app_type] => utility
[patent_app_number] => 13/320629
[patent_app_country] => US
[patent_app_date] => 2010-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7915
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320629
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320629 | Compositions and methods for treating hematological cancers targeting the SIRPa CD47 interaction | May 13, 2010 | Issued |
| 12/600639 | USE OF AUTO-ANTIBODIES AGAINST CD28 AS A PROGNOSTIC MARKER IN MALIGNANT MELANOMA | May 6, 2010 | Abandoned |
Array
(
[id] => 7807962
[patent_doc_number] => 20120058916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'DIAGNOSTIC METHODS FOR LIVER DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/319540
[patent_app_country] => US
[patent_app_date] => 2010-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9192
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058916.pdf
[firstpage_image] =>[orig_patent_app_number] => 13319540
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319540 | DIAGNOSTIC METHODS FOR LIVER DISORDERS | Apr 28, 2010 | Abandoned |
Array
(
[id] => 6095284
[patent_doc_number] => 20110002922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'CELL GROWTH INHIBITORS CONTAINING ANTI-GLYPICAN 3 ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/799491
[patent_app_country] => US
[patent_app_date] => 2010-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7491
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002922.pdf
[firstpage_image] =>[orig_patent_app_number] => 12799491
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/799491 | Cell growth inhibitors containing anti-glypican 3 antibody | Apr 25, 2010 | Issued |
Array
(
[id] => 6566845
[patent_doc_number] => 20100234298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'MATRIX PROTEIN COMPOSITIONS FOR INDUCTION OF APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/760074
[patent_app_country] => US
[patent_app_date] => 2010-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8610
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234298.pdf
[firstpage_image] =>[orig_patent_app_number] => 12760074
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/760074 | Matrix protein compositions for induction of apoptosis | Apr 13, 2010 | Issued |
Array
(
[id] => 6379513
[patent_doc_number] => 20100316574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/748250
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13366
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0316/20100316574.pdf
[firstpage_image] =>[orig_patent_app_number] => 12748250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/748250 | Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy | Mar 25, 2010 | Abandoned |
Array
(
[id] => 8081053
[patent_doc_number] => 08147845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions'
[patent_app_type] => utility
[patent_app_number] => 12/726002
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6267
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/147/08147845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12726002
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/726002 | Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions | Mar 16, 2010 | Issued |
Array
(
[id] => 8446066
[patent_doc_number] => 08288116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-16
[patent_title] => 'Methods and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof'
[patent_app_type] => utility
[patent_app_number] => 12/725036
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 110
[patent_no_of_words] => 21736
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12725036
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/725036 | Methods and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof | Mar 15, 2010 | Issued |
Array
(
[id] => 6433989
[patent_doc_number] => 20100278837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'Compositions And Methods For Reducing Cancer And Inflammation'
[patent_app_type] => utility
[patent_app_number] => 12/720348
[patent_app_country] => US
[patent_app_date] => 2010-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 28707
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12720348
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/720348 | Compositions And Methods For Reducing Cancer And Inflammation | Mar 8, 2010 | Abandoned |
Array
(
[id] => 6202420
[patent_doc_number] => 20110065206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents'
[patent_app_type] => utility
[patent_app_number] => 12/713952
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19915
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065206.pdf
[firstpage_image] =>[orig_patent_app_number] => 12713952
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/713952 | Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents | Feb 25, 2010 | Abandoned |
Array
(
[id] => 12017121
[patent_doc_number] => 09809815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Methods and compositions for diagnosis and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/201702
[patent_app_country] => US
[patent_app_date] => 2010-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 30402
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201702
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201702 | Methods and compositions for diagnosis and treatment of cancer | Feb 18, 2010 | Issued |
Array
(
[id] => 8312619
[patent_doc_number] => 20120189645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'Compositions and methods to treat and control tumors'
[patent_app_type] => utility
[patent_app_number] => 12/660034
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 19459
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12660034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/660034 | Compositions and methods to treat and control tumors | Feb 17, 2010 | Abandoned |
Array
(
[id] => 7668995
[patent_doc_number] => 20110318264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/201726
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27678
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201726
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201726 | Methods and compositions for diagnosis and treatment of cancer | Feb 17, 2010 | Issued |
Array
(
[id] => 8126733
[patent_doc_number] => 20120087916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'ANTI-ICAM-1 ANTIBODY, USES AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/203173
[patent_app_country] => US
[patent_app_date] => 2010-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21532
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20120087916.pdf
[firstpage_image] =>[orig_patent_app_number] => 13203173
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203173 | ANTI-ICAM-1 ANTIBODY, USES AND METHODS | Feb 12, 2010 | Abandoned |
Array
(
[id] => 7777245
[patent_doc_number] => 20120040366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'COMPOSITIONS, METHODS AND USES FOR DISEASE DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/148931
[patent_app_country] => US
[patent_app_date] => 2010-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10490
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040366.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148931 | COMPOSITIONS, METHODS AND USES FOR DISEASE DIAGNOSIS | Feb 9, 2010 | Abandoned |
Array
(
[id] => 7580258
[patent_doc_number] => 20110294141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'METHOD FOR ANALYZING PSA AND METHOD FOR DISTINGUISHING PROSTATE CANCER FROM PROSTATIC HYPERTROPHY USING THAT METHOD FOR ANALYZING PSA'
[patent_app_type] => utility
[patent_app_number] => 13/147905
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11867
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294141.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147905
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147905 | Method for analyzing PSA and method for distinguishing prostate cancer from prostatic hypertrophy using that method for analyzing PSA | Feb 3, 2010 | Issued |
Array
(
[id] => 7790515
[patent_doc_number] => 20120052071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'TUMOR MARKERS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/146478
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8537
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20120052071.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146478
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146478 | TUMOR MARKERS AND METHODS OF USE THEREOF | Jan 26, 2010 | Abandoned |